Colin Nash
Senior Principal, US
Colin is a Senior Principal at Windrose. He has over 12 years of experience in the Life Sciences industry, holding a number of senior roles focused on global pricing, market access, and commercialization strategy.
He partners with industry leaders to optimize their global access and commercial outlook through pricing and reimbursement strategy development, value-based trial design, payer/KOL value message creation, and launch readiness assessment. He’s delivered hundreds of engagements spanning over 30 markets in North America, Europe, Asia, and Latin America, with a keen focus in oncology and cell/gene therapy.
Prior to Windrose, Colin was a Principal at Decision Resources Group where he helped lead the Global Pricing and Market Access Consulting Group while overseeing major global client relationships and workstreams. Prior to that, he was Vice President of Market Access at Ipsos (formerly GfK Bridgehead).
Colin holds both of his degrees from Cornell University, the most recent being a Master of Health Administration in Health Policy Analysis and Management.
Away from work, Colin enjoys spending time with his family, travelling, and playing the guitar and bass. He’s an avid New York sports fan.